サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1629270

POC感染症検査の世界市場：技術別・疾患別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2024年～2032年)

Point of Care Infectious Disease Testing Market, By Technology, By Disease, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 303 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
POC感染症検査の世界市場：技術別・疾患別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2024年～2032年)
出版日: 2024年11月02日
発行: AnalystView Market Insights
ページ情報: 英文 303 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

POC (ポイントオブケア) 感染症検査の市場規模は2023年に114億943万米ドルとなり、2024年から2032年にかけてCAGR 4.69%で拡大

POC感染症検査の市場力学

感染症罹患率の上昇が市場の成長を促進すると予測されます。

インフルエンザ、COVID-19、HIV、肝炎、STIなどの感染症の流行が増加するにつれて、迅速でアクセスしやすい検査ソリューションに対する需要が増加しています。POC検査は、即座の治療決定を容易にするタイムリーな結果を提供します。National Center for Biotechnology Informationによると、感染症は依然として世界の罹患率および死亡率の主要原因の1つであり、世界中で年間5,200万人 (33%) 以上が死亡しています。さらに、迅速検査に対する需要の高まりは、市場に成長機会をもたらす可能性があります。しかし、一部のPOC検査の精度と信頼性に関する懸念は、市場の成長を妨げる可能性があります。

POC感染症検査市場：主な考察

弊社リサーチアナリストの分析によると、世界市場は予測期間 (2024-2032年) に約4.69%のCAGRで毎年成長すると推定されます。

技術別に見ると、分子診断が2023年に最大の市場シェアを示すと予測されました。

疾患別では、COVID-19が2023年の主要タイプでした。

エンドユーザー別では、診療所が2023年の主要タイプでした。

地域別では、北米が2023年の主要収益源でした。

POC感染症検査市場：セグメンテーション分析

POC感染症検査の世界市場は、技術、疾患、エンドユーザー、地域に基づいてセグメント化されます。

市場は技術によって3つのセグメントに分類されます：すなわち、ラテラルフロー免疫測定法、凝集試験法、フロースルー試験法／免疫凝集測定法、分子診断法、その他です。このうち、分子診断学は市場で主導的な地位を占めています。この分野では、ポリメラーゼ連鎖反応 (PCR) や次世代シーケンシング (NGS) などの高度な分子学的手法を用い、患者の診療時点またはその近くで実施される感染症の迅速かつ正確な検査が重要視されています。

市場は疾患別に2つの主要カテゴリーに分類されます：HIV POC、クロストリジウム・ディフィシル POC、HBV POC、肺炎または溶連菌関連感染症、呼吸器合胞体ウイルス (RSV) POC、HPV POC、インフルエンザ/インフルエンザ POC、HCV POC、MRSA POC、結核および薬剤耐性結核 POC、HSV POC、COVID-19、その他です。COVID-19セグメントは市場で支配的な地位を占めています。パンデミックは、ウイルスの蔓延を緩和し、患者管理を強化するための迅速かつ正確な検査の緊急の必要性を浮き彫りにしました。

市場はユーザーによって2つのセグメントに分類されます：診療所、病院、在宅自己検査、介護付き高齢者住宅、研究所です。市場では診療所が支配的な地位を占めています。プライマリケア、緊急治療、専門診療所を含むこれらの施設は、現場で検査を実施できることから大きなメリットを得ており、患者管理に関する迅速な意思決定を促進しています。

POC感染症検査市場：地域別分析

同市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカを含む広範な地域にまたがっています。これらの地域は、事業活動に貢献している国に基づいてさらに区分されます。北米は市場成長において主導的な地域であるが、これは主に様々な感染症を特定するための高度なPOC診断の採用が増加しているためです。この地域は、革新的な診断技術の統合を促進する強固な医療インフラの恩恵を受けています。病院、診療所、検査室は、患者のケアを向上させるために、POC検査ソリューションの導入を進めています。国立生物工学情報センターによると、2020年7月13日現在、米国では330万人以上の住民がコロナウイルス感染症2019 (COVID-19) と診断され、13万5,000人以上の死者が報告されています。欧州は、在宅医療サービスの需要増加に牽引され、市場成長第2位の地域にランクされています。

POC感染症検査市場：競合情勢

ポイントオブケア (POC) 感染症検査市場は、迅速かつ高精度な診断ソリューションに対するニーズの高まりに後押しされ、多数の利害関係者による大きな競争によって特徴付けられています。さまざまな企業が医療機関やテクノロジー企業と戦略的提携を結び、検査能力の向上と市場でのプレゼンス拡大を図っています。この競合環境はダイナミックで進化しています。迅速で正確な診断の必要性が高まるにつれ、企業は移り変わる市場の需要や技術革新に機敏に対応し続けなければならないです。

目次

第1章 POC感染症検査市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 POC感染症検査の主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 POC感染症検査市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 POC感染症検査市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 POC感染症検査の市場情勢

  • POC感染症検査の市場シェア分析 (2023年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 POC感染症検査市場：技術別

  • 概要
    • セグメント別シェア分析：技術別
    • ラテラルフロー免疫測定法
    • 凝集試験
    • フロースルー試験/免疫濃縮アッセイ
    • 分子診断
    • その他

第8章 POC感染症検査市場：疾患別

  • 概要
    • セグメント別シェア分析：疾患別
    • HIV POC
    • クロストリジウム・ディフィシル POC
    • HBV POC
    • 肺炎・連鎖球菌関連感染症
    • 呼吸器合胞体ウイルス (RSV) POC
    • HPV POC
    • インフルエンザ/インフルエンザPOC
    • HCV POC
    • MRSA POC
    • 結核と薬剤耐性結核 POC
    • HSV POC
    • COVID-19
    • その他

第9章 POC感染症検査市場：エンドユーザー別

  • 概要
    • セグメント別シェア分析：エンドユーザー別
    • 診療所
    • 病院
    • 在宅自己検査
    • 介護付き高齢者住宅
    • 研究室

第10章 POC感染症検査市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋 (APAC)
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析：POC感染症検査業界

  • 競合ダッシュボード
  • 企業プロファイル
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthineers
    • Becton, Dickinson &Company
    • Abbott
    • Thermo Fisher Scientific Inc
    • Chembio Diagnostics Inc.
    • Trinity Biotech
    • Cardinal Health
    • Quest Diagnostics Incorporated
    • Bio-Rad Laboratories Inc.
    • bioMerieux SA
    • Sight Diagnostics Ltd.
    • Gene POC
    • Trivitron Healthcare
    • OJ-Bio Ltd.
    • Ortho-Clinical Diagnostics.
    • Others

第12章 AnalystViewの全方位的分析

目次
Product Code: ANV4443

REPORT HIGHLIGHT

Point of Care Infectious Disease Testing Market size was valued at USD 11,409.43 million in 2023, expanding at a CAGR of 4.69% from 2024 to 2032.

Point of Care Infectious Disease Testing (POC IDT) refers to diagnostic tests conducted at or near the site of patient care, allowing for the rapid detection of infectious diseases. This approach enables healthcare providers to obtain immediate results, facilitating timely diagnosis and treatment decisions without the need to send samples to a central laboratory. POC IDT represents a significant progression in healthcare, offering rapid and accessible diagnostic solutions that enhance patient care and contribute positively to public health outcomes.

Point of Care Infectious Disease Testing Market- Market Dynamics

Rising Incidence of Infectious Diseases is expected to drive the growth of the market.

As the prevalence of infectious diseases such as influenza, COVID-19, HIV, hepatitis, and STIs rises, the demand for rapid and accessible testing solutions increases. POC tests provide timely results that facilitate immediate treatment decisions. According to the National Center for Biotechnology Information, Infectious diseases remain one of the leading causes of morbidity and mortality around the world accounting for more than 52 million (33%) annual deaths worldwide. Furthermore, Growing Demand for Rapid Testing may create growth opportunities for the market. However, Concerns about the accuracy and reliability of some POC tests can hinder market growth.

Point of Care Infectious Disease Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.69% over the forecast period (2024-2032)

Based on Technology segmentation, Molecular Diagnostics was predicted to show maximum market share in the year 2023

Based on Disease segmentation, COVID-19 was the leading type in 2023

Based on End-User segmentation, Clinics was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Point of Care Infectious Disease Testing Market- Segmentation Analysis:

The Global Point of Care Infectious Disease Testing Market is segmented based on Technology, Disease, End-User, and Region.

The market is classified into three segments according to technology: Lateral Flow Immunoassay, Agglutination Test, Flow-through Test/Immunoconcentration Assay, Molecular Diagnostics, and Others. Among these, Molecular Diagnostics holds a leading position in the market. This segment emphasizes the importance of swift and precise testing for infectious diseases conducted at or near the point of patient care, employing sophisticated molecular methods such as polymerase chain reaction (PCR) and next-generation sequencing (NGS).

The market is classified into two primary categories based on diseases: HIV POC, Clostridium Difficile POC, HBV POC, pneumonia or Streptococcus-associated infections, Respiratory Syncytial Virus (RSV) POC, HPV POC, Influenza/Flu POC, HCV POC, MRSA POC, TB and drug-resistant TB POC, HSV POC, COVID-19, and others. The COVID-19 segment holds a dominant position in the market. The pandemic underscored the urgent necessity for swift and precise testing to mitigate the virus's spread and enhance patient management.

The market is categorized into two segments according to the Users: Clinics, Hospitals, Home and Self Testing, Assisted Living Healthcare Facilities, and Laboratories. Clinics hold a dominant position within the market. These facilities, which encompass primary care, urgent care, and specialty clinics, gain significant advantages from the capability to conduct tests on-site, facilitating prompt decision-making regarding patient management.

Point of Care Infectious Disease Testing Market- Geographical Insights

This market is geographically extensive, encompassing North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These areas are further segmented based on the countries contributing to business activities. North America is the leading region in market growth, primarily due to the rising adoption of advanced point-of-care diagnostics for identifying various infectious diseases. The region benefits from a robust healthcare infrastructure that facilitates the integration of innovative diagnostic technologies. Hospitals, clinics, and laboratories are progressively implementing point-of-care testing solutions to improve patient care. According to the National Center for Biotechnology Information, as of July 13, 2020, over 3.3 million residents in the United States have been diagnosed with coronavirus disease 2019 (COVID-19), with more than 135,000 fatalities reported. Europe ranks as the second-largest region for market growth, driven by an increasing demand for home healthcare services.

Point of Care Infectious Disease Testing Market- Competitive Landscape:

The market for point-of-care (POC) Infectious Disease Testing is marked by significant competition among numerous stakeholders, fueled by the increasing need for swift and precise diagnostic solutions. A variety of companies are engaging in strategic alliances with healthcare organizations and technology enterprises to improve their testing capabilities and broaden their market presence. This competitive environment is dynamic and evolving. As the necessity for rapid and accurate diagnostics escalates, companies must remain agile in responding to shifting market demands and technological innovations.

Recent Developments:

On July 29, 2024, Roche announced the successful completion of its acquisition of LumiraDx's Point of Care technology, having obtained all necessary antitrust and regulatory approvals. Roche will now proceed with the comprehensive integration of the innovative multi-assay point-of-care platform, along with the associated research and development, operational, and commercial facilities, into its global organization.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers
  • Becton, Dickinson & Company
  • Abbott
  • Thermo Fisher Scientific Inc
  • Chembio Diagnostics Inc.
  • Trinity Biotech
  • Cardinal Health
  • Quest Diagnostics Incorporated
  • Bio-Rad Laboratories Inc.
  • bioMerieux SA
  • Sight Diagnostics Ltd.
  • Gene POC
  • Trivitron Healthcare
  • OJ-Bio Ltd.
  • Ortho-Clinical Diagnostics.
  • Others

GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Lateral Flow Immunoassay
  • Agglutination Test
  • Flow-through test/Immunoconcentration Assay
  • Molecular Diagnostics
  • Others

GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET, BY DISEASE- MARKET ANALYSIS, 2019 - 2032

  • HIV POC
  • Clostridium Difficile POC
  • HBV POC
  • Pneumonia Or Streptococcus Associated Infections
  • Respiratory Syncytial Virus (RSV) POC
  • HPV POC
  • Influenza/Flu POC
  • HCV POC
  • MRSA POC
  • TB & Drug-resistant TB POC
  • HSV POC
  • COVID-19
  • Other

GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Clinics
  • Hospitals
  • Home and Self Testing
  • Assisted Living Healthcare Facilities
  • Laboratory

GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Point of Care Infectious Disease Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Point of Care Infectious Disease Testing Market Snippet by Technology
    • 2.1.2. Point of Care Infectious Disease Testing Market Snippet by Disease
    • 2.1.3. Point of Care Infectious Disease Testing Market Snippet by End-User
    • 2.1.4. Point of Care Infectious Disease Testing Market Snippet by Country
    • 2.1.5. Point of Care Infectious Disease Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Point of Care Infectious Disease Testing Key Market Trends

  • 3.1. Point of Care Infectious Disease Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Point of Care Infectious Disease Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Point of Care Infectious Disease Testing Market Opportunities
  • 3.4. Point of Care Infectious Disease Testing Market Future Trends

4. Point of Care Infectious Disease Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Point of Care Infectious Disease Testing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Point of Care Infectious Disease Testing Market Landscape

  • 6.1. Point of Care Infectious Disease Testing Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Point of Care Infectious Disease Testing Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 7.1.2. Lateral Flow Immunoassay
    • 7.1.3. Agglutination Test
    • 7.1.4. Flow-through test/Immunoconcentration Assay
    • 7.1.5. Molecular Diagnostics
    • 7.1.6. Others

8. Point of Care Infectious Disease Testing Market - By Disease

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease, 2023 & 2032 (%)
    • 8.1.2. HIV POC
    • 8.1.3. Clostridium Difficile POC
    • 8.1.4. HBV POC
    • 8.1.5. Pneumonia Or Streptococcus Associated Infections
    • 8.1.6. Respiratory Syncytial Virus (RSV) POC
    • 8.1.7. HPV POC
    • 8.1.8. Influenza/Flu POC
    • 8.1.9. HCV POC
    • 8.1.10. MRSA POC
    • 8.1.11. TB & Drug-resistant TB POC
    • 8.1.12. HSV POC
    • 8.1.13. COVID-19
    • 8.1.14. Other

9. Point of Care Infectious Disease Testing Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Clinics
    • 9.1.3. Hospitals
    • 9.1.4. Home and Self Testing
    • 9.1.5. Assisted Living Healthcare Facilities
    • 9.1.6. Laboratory

10. Point of Care Infectious Disease Testing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Point of Care Infectious Disease Testing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Point of Care Infectious Disease Testing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Point of Care Infectious Disease Testing Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Point of Care Infectious Disease Testing Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Point of Care Infectious Disease Testing Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Point of Care Infectious Disease Testing Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. F. Hoffmann-La Roche Ltd
    • 11.2.2. Siemens Healthineers
    • 11.2.3. Becton, Dickinson & Company
    • 11.2.4. Abbott
    • 11.2.5. Thermo Fisher Scientific Inc
    • 11.2.6. Chembio Diagnostics Inc.
    • 11.2.7. Trinity Biotech
    • 11.2.8. Cardinal Health
    • 11.2.9. Quest Diagnostics Incorporated
    • 11.2.10. Bio-Rad Laboratories Inc.
    • 11.2.11. bioMerieux SA
    • 11.2.12. Sight Diagnostics Ltd.
    • 11.2.13. Gene POC
    • 11.2.14. Trivitron Healthcare
    • 11.2.15. OJ-Bio Ltd.
    • 11.2.16. Ortho-Clinical Diagnostics.
    • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us